Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in chemico
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 08-08-2019 to 10-10-2019
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 020
- Report date:
- 2020
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 442C (In Chemico Skin Sensitisation Assays addressing the Adverse Outcome Pathway key event on covalent binding to proteins)
- Version / remarks:
- 18 June 2019
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- other: Direct Peptide Reactivity Assay (DPRA)
Test material
- Reference substance name:
- (4E)-2,4-dimethyl-5-(4-methylphenyl)pent-4-enal
- Cas Number:
- 1226911-73-4
- Molecular formula:
- C14H18O
- IUPAC Name:
- (4E)-2,4-dimethyl-5-(4-methylphenyl)pent-4-enal
- Test material form:
- liquid
- Details on test material:
- - Physical state: Liquid
- Storage condition of test material: approximately 4ºC, in the dark and under nitrogen
- Other: colourless liquid
Constituent 1
In chemico test system
- Details of test system:
- cysteine peptide, (Ac-RFAACAA-COOH)
- lysine peptide (Ac-RFAAKAACOOH)
- Details on the study design:
- PREPARATION OF TEST SOLUTIONS
- Preparation of the peptide/derivative stock solutions:
Stock solutions of each peptide at concentrations of 0.667 mM were prepared by dissolution of pre-weighed aliquots of the appropriate peptide in ca 20 mL aliquots of the appropriate buffer solution (Cysteine in 100 mM phosphate buffer pH 7.5, Lysine in 100 mM Ammonium acetate buffer pH 10.2).
Calibration standards of both peptides were prepared by diluting the requisite stock solution in the appropriate buffer and acetonitrile and contained each peptide at concentrations of 0.0167 mM, 0.0334 mM, 0.0667 mM, 0.133 mM, 0.267 mM and 0.534 mM. A buffer blank was prepared as well.
- Preparation of the test chemical solutions:
100 mM stock solutions of the test item were prepared in acetonitrile for both analytical occasions.
Triplicate solutions each of test item and the positive control stocks were diluted with the Cysteine peptide to prepare final solutions containing 0.5 mM Cysteine and 5 mM of either the test item or the positive control. Also triplicate solutions each of test item and the positive control stocks were diluted with the Lysine peptide to prepare solutions containing 0.5 mM Lysine and 25 mM of either the test item or the positive control.
- Preparation of the positive controls, reference controls and co-elution controls:
Positive controls: The positive control chemical (Cinnamic Aldehyde) was prepared at a concentration of 100 mM in acetonitrile.
Triplicate solutions each of test item and the positive control stocks were diluted with the Cysteine peptide to prepare final solutions containing 0.5 mM Cysteine and 5 mM of either the test item or the positive control. Also triplicate solutions each of test item and the positive control stocks were diluted with the Lysine peptide to prepare solutions containing 0.5 mM Lysine and 25 mM of either the test item or the positive control.
Reference controls: Stability controls (Reference Control B, n=6) and precision controls (Reference control A) of both peptides were prepared at a concentration of 0.5 mM. Reference Control A and Reference Control B were prepared with buffer and acetonitrile.
Co-elution controls: For the co-elution controls, blank buffer solutions were used in place of the Cysteine and Lysine stock solutions.
INCUBATION
- Incubation conditions: The appearance of the test item and positive control samples in the HPLC vials was documented after preparation and then the vials placed into the autosampler of the HPLC set at 25°C for a minimum of 22 hours incubation prior to injection on the analysis run. Prior to injection of the samples the appearance of the samples in the vials was assessed and documented again.
- Precipitation noted: Precipitation not observed.
PREPARATION OF THE HPLC
- Standard calibration curve for both Cys and Lys:
Calibration standards of both peptides were prepared by diluting the requisite stock solution in the appropriate buffer and acetonitrile and contained each peptide at concentrations of 0.0167 mM, 0.0334 mM, 0.0667 mM, 0.133 mM, 0.267 mM and 0.534 mM. A buffer blank was prepared as well.
Calibration curve is available in the full study report. The calibration curve met the acceptability criteria: standard calibration curve having an r2 > 0.99.
- Verification of the suitability of the HPLC for test chemical and control substances:
The mean peptide concentration of Reference controls B was 0.491 mM and 0.507 mM for both Cysteine and Lysine. they both were within the acceptance criteria of 0.45-0.55 mM. This confirms the suitability of the HPLC system and indicates that the solvent (ACN, acetonitrile) used to dissolve the test item did not impact the Percent SPCC nor SPCL Depletion.
DATA EVALUATION
- Cys and Lys peptide detection wavelength: The relative peptide concentration is measured by high-performance liquid chromatograph (HPLC) with gradient elution and spectrophotometric detection at 220 nm. - Vehicle / solvent:
- acetonitrile
- Positive control:
- cinnamic aldehyde
Results and discussion
In vitro / in chemico
Resultsopen allclose all
- Key result
- Group:
- test chemical
- Run / experiment:
- mean
- Parameter:
- cysteine depletion
- Value:
- 1.41 %
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Group:
- test chemical
- Run / experiment:
- mean
- Parameter:
- lysine depletion
- Value:
- 2.18 %
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Remarks on result:
- no indication of skin sensitisation
- Outcome of the prediction model:
- no or minimal reactivity [in chemico]
- Other effects / acceptance of results:
- OTHER EFFECTS:
- Visible damage on test system: No phase separation neither precipitation occurred after the incubation period for both Cysteine and Lysine samples.
DEMONSTRATION OF TECHNICAL PROFICIENCY: The study protocol was validated with the proficiency chemicals prescribed in the OECD test guideline 442C.
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: All criteria met.
- Acceptance criteria met for positive control: All criteria met.
- Acceptance criteria met for reference controls A to C: All criteria met.
- Acceptance criteria met for co-elution controls (Lysine and Cysteine): All criteria met.
- Acceptance criteria met for variability between replicate measurements: All criteria met.
- Range of historical values if different from the ones specified in the test guideline: Not applicable.
Any other information on results incl. tables
Table 1: Acceptability of the DPRA
CV: Coefficient of Variation
Table 2: Depletion of peptide in the presence of the test item
| Mean peak area of reference control (µV.sec) | Mean peak area of peptide with test item (µV.sec) | Mean depletion (%) |
Cysteine | B: 903730 (n=6) | 890990 (n=3) | 1.41 |
Lysine | B: 721990 (n=6) | 706290 (n=3) | 2.18 |
Table 3: Results of the DPRA with the test item
| SPCC depletion | SPCL depletion | Mean of SPCC and SPCL depletion | DPRA prediction and reactivity classification | ||
Mean | ± SD | Mean | ± SD | Cysteine 1:10 / Lysine 1:50 prediction model | ||
Test Item | 1.41% | 0.71% | 2.18% | 2.93% | 1.79% | Negative: No or minimal reactivity |
SD: Standard Deviation
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Remarks:
- Test item was negative in the DPRA and was classified in the "no or minimal reactivity class when using the Cysteine 1:10 / Lysine 1:50 prediction model.
- Conclusions:
- The test item gave a negative in DPRA and was classified in the "Negative: No or minimal reactivity class" using the Cysteine 1:10 / Lysine 1:50 prediction model. The result will be considered within a weight of evidence assessment for Classification and Labelling purposes.
- Executive summary:
The purpose of this study (based on the OECD guideline for the testing of chemicals, In chemico Skin Sensitisation: Direct Peptide Reactivity Assay (DPRA), OECD/OCDE document TG 442C, 18 June 2019) was to assess the reactivity and sensitising potential of the test item, ST 08 C 19. Solutions of this test item were incubated with two synthetic peptides (containing respectively a cysteine and a lysine amino acid) for approximate 24 hours and then the concentration of each peptide was measured relative to a series of peptide control solutions.
Solutions of the test item in acetonitrile were successfully analysed by the validated DPRA analytical method (analytical method FIA/M101/15) in both the Cysteine and Lysine containing synthetic peptides. For each peptide analysis all acceptance criteria were met (linearity of standard response, reference and stability control concentrations, positive control depletion and test item reproducibility). There was no co-elution of test item with either peptide.
Under the conditions of this study, there was no or minimal depletion (mean depletion of 1.79%) of either the Cysteine or Lysine peptides in the presence of the test item, the DPRA assay categorises this test item as negative and hence it is predicted not to be a skin sensitiser.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.